Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1573-7217

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin ; day:25 ; month:2 ; year:2016 ; pages:1-11
Breast cancer research and treatment ; (25.2.2016), 1-11

Creator: Turturro, Sanja B.

Contributor: Najor, Matthew S.
Ruby, Carl E.
Cobleigh, Melody A.
Abukhdeir, Abde M.
SpringerLink (Online service)

DOI: 10.1007/s10549-016-3729-8

URN: urn:nbn:de:1111-201602274159

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Turturro, Sanja B.
Najor, Matthew S.
Ruby, Carl E.
Cobleigh, Melody A.
Abukhdeir, Abde M.
SpringerLink (Online service)

Other Objects (12)

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Related objects

Reset password